Skip to main content
Clinical Trials/NCT06156722
NCT06156722Active, not recruitingNot Applicable

The Combination of Sperm Selection by IMSI and Hyaluronic Acid Binding Assay Improves ICSI Outcomes: A Randomized Prospective Sibling-oocytes Study

Meir Medical Center1 site in 1 country189 target enrollmentStarted: March 1, 2019Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Active, not recruiting
Enrollment
189
Locations
1
Primary Endpoint
Pregnancy and delivery rates

Study Overview

Brief Summary

In this prospective randomized sibling-oocytes blinded study, investigators examine the combination of two sperm selection methods that logically seem to complete each other, and potentially may improve ICSI outcomes.

The methods include the selection of the optimal spermatozoa based on its morphology by IMSI, together with its physiological function of binding to HA by Spermslow (SS).

The current study compared a group of ET after sperm selection by IMSI with SS to a group of ET after sperm selection by IMSI-only without SS, and to a mixed ET group where two embryos were transferred, one after IMSI-only and the other one after IMSI with SS.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover
Primary Purpose
Other
Masking
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to 38 Years (Adult)
Sex
Female
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •females ages 38 or younger retrieval of at least 5 mature oocytes and fresh ejaculate samples

Exclusion Criteria

  • •frozen embryos surgically extracted sperm preparations embryo-biopsy cycles

Arms & Interventions

The IMSI-only group

Active Comparator

The IMSI-only group

Intervention: Sperm selection by IMSI (Procedure)

IMSI with SpermSlow group

Active Comparator

IMSI with SpermSlow group

Intervention: Sperm selection by IMSI and spermslow (Procedure)

Mixed embryo group

No Intervention

Mixed embryo group

Outcomes

Primary Outcomes

Pregnancy and delivery rates

Time Frame: Within up to 10 month from treatment

Pregnancy and delivery rates

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Yael Yagur

Consultant, Obstetrics and Gynaecology Department. Principal investigator. Lecturer.

Meir Medical Center

Study Sites (1)

Loading locations...

Similar Trials

The Combination of Sperm Selection by IMSI... | Clinical Trial